Tian Zhang

Also affiliated with Southwestern Medical Center, Shandong Provincial Hospital, Shandong First Medical University, Yueqing People's Hospital, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.300Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology

Frontiers in Neuroscience(2023)10.3389/fnins.2022.1111763

Top 55%

0.300DataRank

Top 55%5 citations

Tyler E. Kittel, Renaid B. Kim, Thao-Nguyen Bach, Tian Zhang, Cassie S. Mitchell +1 more

Papers

Driven by 36 papers — median percentile 45. Top paper: “A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial”.

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

The Lancet(2021)10.1016/s0140-6736(21)00152-5

N/A

6.9DataRank · unranked

283 citations

Catherine M. Tangen, Ian M. Thompson, Naomi Balzer-Haas, Daniel J. George, Daniel Y.C. Heng +15 more

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3441

N/A

1.6DataRank · unranked

45 citations

Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh +15 more

Facts and Hopes for Immunotherapy in Renal Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2372

N/A

0.538DataRank · unranked

35 citations

Tian Zhang, Tuoqi Wu, James Brugarolas, Chen Yao

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer

Cancer(2020)10.1002/cncr.33067

N/A

0.538DataRank · unranked

35 citations

Michael R. Harrison, Peter H. O’Donnell, Ajjai Alva, Noah M. Hahn, Leonard J. Appleman +17 more

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape

The Oncologist(2022)10.1093/oncolo/oyab056

N/A

0.510DataRank · unranked

29 citations

Chris Labaki, Georgia Sofia Karachaliou, Toni K. Choueiri, Tian Zhang, Shuchi Gulati

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma

Cancers(2022)10.3390/cancers14153830

N/A

0.442DataRank · unranked

18 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study

JU Open Plus(2024)10.1097/ju9.0000000000000118

N/A

0.312DataRank · unranked

7 citations

Karissa Tu, J. Kelly Davis, Ada Campagna, Sharron L. Docherty, Jeremy Kurnot +4 more

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology

Frontiers in Neuroscience(2023)10.3389/fnins.2022.1111763

Top 55%

0.300DataRank

Top 55%5 citations

Tyler E. Kittel, Renaid B. Kim, Thao-Nguyen Bach, Tian Zhang, Cassie S. Mitchell +1 more

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.010

N/A

0.241DataRank · unranked

4 citations

Michaela A. Dinan, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.106

N/A

0.104DataRank · unranked

1 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, C.D. Baggett +6 more

Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.270

N/A

0DataRank · unranked

9 citations

Catherine M. Tangen, Ian M. Thompson, Naomi B. Haas, Daniel J. George, Daniel Yick Chin Heng +15 more

Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.396

N/A

0DataRank · unranked

8 citations

Michael R. Harrison, Allison M. Deal, Chelsea K. Osterman, Sundhar Ramalingam, Young E. Whang +12 more

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.280

N/A

0DataRank · unranked

1 citations

Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica Pritchard, Tian Zhang +5 more

A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4507

N/A

0DataRank · unranked

1 citations

Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh, Yung Lyou +15 more

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4304

N/A

0DataRank · unranked

72 citations

Sonya Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson +95 more

Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis

Biosensors and Bioelectronics(2022)10.1016/j.bios.2022.114445

N/A

0DataRank · unranked

34 citations

Woo‐Jin Jeong, Roya Jafari, Luke J. Kubiatowicz, Ashita Nair, Michael J. Poellmann +15 more

Tissue engineered cancer metastases as cancer vaccine to improve cancer immunotherapy

Acta Biomaterialia(2022)10.1016/j.actbio.2022.09.059

N/A

0DataRank · unranked

4 citations

Umer Ahmed, Jonathan T. Peters, Tian Zhang, Andrew Z. Wang, Nikhila Sultanpuram

Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma

Journal of Geriatric Oncology(2022)10.1016/j.jgo.2021.12.012

N/A

0DataRank · unranked

3 citations

Lauren E. Wilson, Melissa A. Greiner, Jessica Pritchard, Tian Zhang, Deborah R. Kaye +5 more

Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4527

N/A

0DataRank · unranked

2 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.300

N/A

0DataRank · unranked

0 citations

Lauren E. Wilson, Bradford E. Jackson, Lisa P. Spees, Christopher D. Baggett, Melissa A. Greiner +10 more

Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model

Neoplasia(2022)10.1016/j.neo.2022.100864

N/A

0DataRank · unranked

0 citations

Shivani Sud, Yanli Qu, Liantao Li, Jiajie Zhang, David Marron +8 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion

UNC Libraries(2024)10.17615/8m78-3e90

N/A

0DataRank · unranked

0 citations

Cameron J. Bloomquist, Yu Mi, Stephanie A. Montgomery, Kyle Wagner, Youli Xia +5 more

Tissue engineered cancer metastases as cancer vaccine to improve cancer immunotherapy

UNC Libraries(2024)10.17615/amrc-j429

N/A

0DataRank · unranked

0 citations

Jonathan T. Peters, Nikhila Sultanpuram, Tian Zhang, Andrew Z. Wang, Umer Ahmed

Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation

Nature Communications(2020)10.1038/s41467-020-15424-4

N/A

0DataRank · unranked

106 citations

John D. Nagy, Travis Gerke, Tian Zhang, Andrew Z. Wang, Jingsong Zhang +3 more

Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy

medRxiv(2025)10.1101/2025.11.19.25340277

N/A

0DataRank · unranked

0 citations

Alana Christie, Vipul Jarmale, Farzad Tahmasebi, Bingqing Xie, Jeffrey Miyata +9 more

Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.22.050385

N/A

0DataRank · unranked

14 citations

Santosh Gupta, Jared Eng, Gabor Kemeny, Bhairavy Puviindran, Wen‐Chi Foo +18 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps760

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +7 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5100

N/A

0DataRank · unranked

9 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001792

N/A

0DataRank · unranked

115 citations

Matthew D. Tucker, Ramy Sedhom, Eric Schwartz, Jason Zhu, Chester Kao +12 more

Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics

Neoplasia(2021)10.1016/j.neo.2021.06.013

N/A

0DataRank · unranked

45 citations

Jingsong Zhang, Tian Zhang, Andrew Z. Wang, Robert J. Butler, Robert A. Gatenby +2 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

Kidney Cancer(2021)10.3233/kca-210119

N/A

0DataRank · unranked

9 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, Christopher D. Baggett +6 more

Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts

Oncogene(2021)10.1038/s41388-021-02075-y

N/A

0DataRank · unranked

9 citations

Sabin Dhakal, Laura M. Selfors, Chandler M. Friend, Tian Zhang, Maurizio Callari +10 more

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Cancer Medicine(2021)10.1002/cam4.4201

N/A

0DataRank · unranked

4 citations

Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps366

N/A

0DataRank · unranked

26 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

Tian Zhang

Indexed papers

Top data-sharing exemplar

Papers